Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma

NCT02428751 ·Status: UNKNOWN ·Phase: PHASE3

A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

NCT00169156 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

NCT05040906 ·Status: UNKNOWN ·Phase: PHASE3

R2-CHOP in Untreated DEL-DLBCL：An Open-lable，Multicenter，Phase II Study

NCT04842487 ·Status: UNKNOWN ·Phase: PHASE2

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

NCT01087424 ·Status: COMPLETED ·Phase: PHASE2

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

NCT02660710 ·Status: COMPLETED ·Phase: PHASE2

Split-Dose R-CHOP for Older Adults With DLBCL

NCT03943901 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)

NCT00450385 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

NCT00209222 ·Status: UNKNOWN ·Phase: PHASE3

Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma

NCT03200015 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

NCT02285062 ·Status: COMPLETED ·Phase: PHASE3

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

NCT03003520 ·Status: COMPLETED ·Phase: PHASE2

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

NCT04164368 ·Status: COMPLETED ·Phase: PHASE2

Phase Ib Study of Rocbrutinib in Combination with R-CHOP in Patients with Newly Diagnosed B-cell Non-Hodgkin Lymphoma

NCT06251180 ·Status: RECRUITING ·Phase: PHASE1

Reduced Chemotherapy in Low Risk DLBCL

NCT02752815 ·Status: UNKNOWN ·Phase: PHASE4

A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

NCT02867566 ·Status: COMPLETED ·Phase: PHASE3

Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00058422 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

NCT06573645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

NCT03650933 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

NCT06760039 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

NCT06594432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma

NCT01393756 ·Status: COMPLETED ·Phase: PHASE2

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

NCT04214626 ·Status: COMPLETED ·Phase: PHASE2

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 ·Status: COMPLETED ·Phase: PHASE2

Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

NCT05498259 ·Status: UNKNOWN ·Phase: PHASE2